The closing price of NRX Pharmaceuticals Inc (NASDAQ: NRXP) was $0.70 for the day, up 5.67% from the previous closing price of $0.66. In other words, the price has increased by $+0.0376 from its previous closing price. On the day, 4862881 shares were traded. NRXP stock price reached its highest trading level at $0.7300 during the session, while it also had its lowest trading level at $0.5650.
Ratios:
Our analysis of NRXP’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.68 and its Current Ratio is at 0.68.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 30 ’23 when Hurvitz Chaim bought 70,000 shares for $0.29 per share. The transaction valued at 20,125 led to the insider holds 570,000 shares of the business.
Gorovitz Aaron bought 35,000 shares of NRXP for $11,196 on Aug 30 ’23. The Director now owns 105,000 shares after completing the transaction at $0.32 per share. On Aug 23 ’23, another insider, Javitt Jonathan C, who serves as the Chief Scientist of the company, bought 100,000 shares for $0.33 each. As a result, the insider paid 33,000 and bolstered with 446,332 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRXP now has a Market Capitalization of 60.16M and an Enterprise Value of 61.33M.
Stock Price History:
Over the past 52 weeks, NRXP has reached a high of $1.20, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is 0.4367, while the 200-Day Moving Average is calculated to be 0.3927.
Shares Statistics:
NRXP traded an average of 1.53M shares per day over the past three months and 3.49M shares per day over the past ten days. A total of 66.44M shares are outstanding, with a floating share count of 61.08M. Insiders hold about 33.38% of the company’s shares, while institutions hold 4.34% stake in the company. Shares short for NRXP as of Feb 15, 2024 were 3.87M with a Short Ratio of 2.53, compared to 2.92M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.54% and a Short% of Float of 6.78%.
Earnings Estimates
The firm’s stock currently is rated by 3 analysts. On average, analysts expect EPS of -$0.07 for the current quarter, with a high estimate of -$0.05 and a low estimate of -$0.08, while EPS last year was -$0.16. The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.08 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.41 and -$0.42 for the fiscal current year, implying an average EPS of -$0.42. EPS for the following year is -$0.27, with 3 analysts recommending between -$0.1 and -$0.4.
